{
    "eid": "2-s2.0-85142131791",
    "title": "Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials",
    "cover-date": "2022-11-03",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "dysbiosis",
        "fecal microbiota transplantation",
        "gastrointestinal diseases",
        "irritable bowel syndrome",
        "meta-analysis"
    ],
    "authors": [
        "Chatpol Samuthpongtorn",
        "Piyawat Kantagowit",
        "Rapat Pittayanon",
        "Tanisa Patcharatrakul",
        "Sutep Gonlachanvit"
    ],
    "citedby-count": 3,
    "ref-count": 63,
    "ref-list": [
        "Bowel disorders",
        "Irritable bowel syndrome",
        "The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: A Rome Foundation working team literature review",
        "The impact of irritable bowel syndrome on health-related quality of life",
        "The burden of IBS: Looking at metrics",
        "Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study",
        "Irritable bowel syndrome: A clinical review",
        "Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome",
        "Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome",
        "Irritable bowel syndrome: A gut microbiota-related disorder?",
        "Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome",
        "The gut microbiome and irritable bowel syndrome",
        "Gut Microbiota in patients with irritable bowel syndrome\u2013a systematic review",
        "Systematic review with meta-analysis: The efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome",
        "A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome",
        "Pharmacomicrobiomics: Exploiting the drug-microbiota interactions in anticancer therapies",
        "Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study",
        "Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: Short- and long-term results from a placebo-controlled randomized trial",
        "Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: A double-blind, randomised, placebo-controlled, parallel-group, single-centre trial",
        "Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: Results from a randomised, double-blind placebo-controlled study",
        "Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: A double-blind, randomised, placebo-controlled trial",
        "Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century",
        "Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis of randomized controlled trials",
        "Efficacy of fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials",
        "Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation",
        "Design of treatment trials for functional gastrointestinal disorders",
        "Design of treatment trials for functional gastrointestinal disorders",
        "Quantifying heterogeneity in a meta-analysis",
        "Fecal microbiota transplantation: An update on clinical practice",
        "Treating clostridium difficile infection with fecal microbiota transplantation",
        "American journal of gastroenterology lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. Difficile infection",
        "Faecal transplantation for the treatment of Clostridium difficile infection: A review",
        "European consensus conference on faecal microbiota transplantation in clinical practice",
        "The use of faecal microbiota transplant as treatment for recurrent or refractory clostridium difficile infection and other potential indications: Joint British society of gastroenterology (BSG) and healthcare infection society (HIS) guidelines",
        "International consensus conference on stool banking for faecal microbiota transplantation in clinical practice",
        "Scientific frontiers in faecal microbiota transplantation: Joint document of asia-pacific association of gastroenterology (APAGE) and asia-pacific society for digestive endoscopy (APSDE)",
        "Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice",
        "The effect of allogenic versus autologous fecal microbiota transfer on symptoms, visceral perception and fecal and mucosal microbiota in irritable bowel syndrome: A randomized controlled study",
        "Randomised clinical trial: Faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome",
        "Assessment of abdominal pain through global outcomes and recent FDA recommendations in children: Are we ready for change?",
        "Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection",
        "Durable coexistence of donor and recipient strains after fecal microbiota transplantation",
        "Long-term follow-up results of fecal microbiota transplantation for irritable bowel syndrome: A single-center, retrospective study",
        "Increasing the dose and/or repeating faecal microbiota transplantation (FMT) increases the response in patients with irritable bowel syndrome (IBS)",
        "An update for pharmacologists on new treatment options for inflammatory bowel disease: The clinicians\u2019 perspective",
        "Clinical application and potential of fecal microbiota transplantation",
        "Part 2: Treatments for chronic gastrointestinal disease and gut dysbiosis",
        "Alteration of the gut microbiota in Chinese population with chronic kidney disease",
        "Chapter 10 \u2013 Monitoring microbiota in chickens and pigs",
        "Short-chain fatty acid and vitamin production potentials of Lactobacillus isolated from fermented foods of Khasi Tribes, Meghalaya, India",
        "Gut microbiota-derived propionate regulates the expression of Reg3 mucosal lectins and ameliorates experimental colitis in mice",
        "Maternal carriage of prevotella during pregnancy associates with protection against food allergy in the offspring",
        "Allicin-induced host-gut microbe interactions improves energy homeostasis",
        "Faecalibacterium prausnitzii: From microbiology to diagnostics and prognostics",
        "Efficacy of fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis",
        "Fecal microbiota transplantation (FMT) with colonoscopy is superior to enema and nasogastric tube while comparable to capsule for the treatment of recurrent clostridioides difficile infection: A systematic review and meta-analysis",
        "Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis",
        "Delivery routes for faecal microbiota transplants: Available, anticipated and aspired",
        "Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection: A randomized clinical trial",
        "Reducing cost and complexity of fecal microbiota transplantation using universal donors for recurrent clostridium difficile infection",
        "Seeking safe stool: Canada needs a universal donor model",
        "Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Ratchadapiseksompotch Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}